Dabigatran plasma concentration indicated the risk of patients with non-valvular atrial fibrillation
Z Zhu, Z Shen, A Shi, C Su, J Mao, H Tao, F Xu, Z Hu… - Heart and Vessels - Springer
This study aimed to evaluate the variability of dabigatran plasma concentration and the
association with clinical events in Chinese patients treated with dabigatran etexilate (DE) for …
association with clinical events in Chinese patients treated with dabigatran etexilate (DE) for …
Dabigatran plasma concentration indicated the risk of patients with non-valvular atrial fibrillation.
Z Zhu, Z Shen, A Shi, C Su, J Mao, H Tao, F Xu… - Heart and …, 2021 - europepmc.org
This study aimed to evaluate the variability of dabigatran plasma concentration and the
association with clinical events in Chinese patients treated with dabigatran etexilate (DE) for …
association with clinical events in Chinese patients treated with dabigatran etexilate (DE) for …
Dabigatran plasma concentration indicated the risk of patients with non-valvular atrial fibrillation
Z Zhu, Z Shen, A Shi, C Su, J Mao, H Tao… - Heart and …, 2022 - pubmed.ncbi.nlm.nih.gov
This study aimed to evaluate the variability of dabigatran plasma concentration and the
association with clinical events in Chinese patients treated with dabigatran etexilate (DE) for …
association with clinical events in Chinese patients treated with dabigatran etexilate (DE) for …
Dabigatran plasma concentration indicated the risk of patients with non-valvular atrial fibrillation.
Z Zhu, Z Shen, A Shi, C Su, J Mao, H Tao… - Heart & …, 2022 - search.ebscohost.com
This study aimed to evaluate the variability of dabigatran plasma concentration and the
association with clinical events in Chinese patients treated with dabigatran etexilate (DE) for …
association with clinical events in Chinese patients treated with dabigatran etexilate (DE) for …